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Abstract
Background: The aim of this study was to assess the prevalence of Human Immunodeficiency Virus (HIV), Hepatitis
B Virus (HBV) and Hepatitis C Virus (HCV) serological markers and the prevalence of VDRL positive subjects in a
population of refugees of various nationalities, living in the Asylum Seeker Centre in Bari Palese, Southern Italy.
Methods: The study was carried out in the period May-July 2008 and recruited only voluntarily enrolled healthy
refugees. HBsAg, anti-HBc, anti-HCV and anti-HIV virus antibodies were detected. VDRL syphilis screening was also
carried out on the serum samples.
Results: A total of 529 refugees, 442 males and 87 females, aged between 7 and 52 years, were studied. Of these,
510 were from Africa and 19 from Asia.
Forty-four individuals (8.3%) were HBsAg positive and 241 (45.6%) were anti-HBc positive. A total of 24 (4.5%) indi-
viduals were anti-HCV positive. Eight asylum seekers (1.5%) were HIV positive. VDRL tests were performed on 269
subjects and 4 (1.5%) were positive. 12.3% of the study population had serological markers of chronic and trans-
missible infections with potential blood-borne or sexual transmission.
Conclusions: In Italy, a suitable protocol is necessary for the early diagnosis of infectious diseases on entering
Asylum Centres, so allowing the adoption of prevention measures to safeguard the health of the individuals, the
residents and workers in the Centres and the general population.
Background
There are estimated to be about 3.8 million immigrants
in Italy, around 6% of the resident population. In 2008
alone the non-Italian population increased by about
500.000. Reliable estimates of immigration movements
can be ascertained from the figures for hirings of non-Ita-
lians by companies and families in recent years. These are
251,000 in 2005, 520,000 in 2006 and 741,000 in 2007.
The immigration movements reported in the last ten
years are among the highest in Italian history [1].
Puglia is a region in southeastern Italy bordering the
Adriatic Sea in the east, the Ionian Sea to the southeast,
and the Strait of Otranto and Gulf of Taranto in the
south. Because of its geographic position, Puglia has
since 1991 been subject to immigration influx, at times
on a large scale, and is recognized to be a “Border
Region” [2].
In recent years there has also been an increase in the
number of people asking for asylum and refugee status
in Italy.
Under Italian law, asylum seekers are housed in Asy-
lum Seeker Centres. There were forty-four centres in
2008, with almost 8000 places available [3]. On arrival
at the Centre, medical controls are carried out only for
scabies and dermatophytosis that are mandatory in Italy.
No screening takes place for infectious diseases of sexual
and parenteral transmission, though this is recom-
mended in the protocols of the Centers for Disease
Control and Prevention (CDC) [4,5].
R e f u g e ep o p u l a t i o n sa r em o r ea tr i s ko fh a v i n gH B V ,
HCV, HIV and sexually transmitted infections (STI).
The contributing factors include: origin from countries
that are highly endemic for these infections [6,7]; lack of
information on STI prevention directed to the migrant
communities in the host country [8]; the predominance
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breaking up of couples and other family ties, and the
exclusion from normal society, exacerbated by the bar-
riers of language, culture and socioeconomic conditions.
The risk of these and other infections is aggravated by
the harsh or chaotic living conditions many refugees
experience before emigration [9].
Currently, Italy is among the countries with the lowest
level of endemic hepatitis B, chronic carriers are around
1.5%, with an acute symptomatic infection rate of 1-2
per 100,000 inhabitants/year and almost no infection in
childhood. Up to the middle 1980’s, HBV was wide-
spread in Italy but since then there has been a rapid
decline in the acute infection rate and also in chronic
infection [10].
The data for hepatitis C show anti-HCV positive sub-
jects at 3% of people under 50 years old, but rising with
age, with highspots of over 40% among the over-60s in
some parts of Italy [10].
In Italy, the rate of new cases of HIV reached a peak
in 1987, falling off to 1998 and then stabilizing at a rate
of about 6 new cases per 100,000 inhabitants/year. This
trend is similar for both males and females but the pro-
portion of females has increased over the years [11].
Assessing the prevalence of viral hepatitis among refu-
gees is necessary for the planning of health control mea-
sures in primary and secondary prevention. Prevention
is of great importance for public health, as chronic viral
hepatitis carries long-term risk of cirrhosis and remains
the main cause for the development of hepatocellular
carcinoma in Europe and worldwide.
The disease Syphilis has been associated with migra-
tion and population mobility through much of recorded
history and today its modern epidemiology can also
represent a demographic indicator for sexually trans-
mitted infections and the international movement of
disease [12].
T h ea i mo ft h i ss t u d yw a st oa s s e s st h ep r e v a l e n c eo f
HIV, hepatitis B and C and treponemal infection serolo-
gical markers in a population of refugees of various
nationalities, living in the Asylum Seeker Centre in Bari
Palese in Puglia, Southern Italy. This screening was
necessary to allow the adoption of both the treatment of
the infected individuals and to put in place the measures
necessary to safeguard the residents and workers in the
Centre.
Methods
In the year 2008, the Asylum Seeker Centre in Bari
received 2,550 immigrants of which 2,222 were males
(87.1%) and 328 females (12.9%), with an average age of
24 years. On arrival at the Centre each new resident
was examined by the Centre’s medical staff. Immigrants
with symptoms or with a positive disease history were
treated as necessary. During the period May-July 2008,
immigrants who were in apparent good health and did
not report signs or symptoms in the recent or remote
past were asked if they wished to undergo the testing
after its importance had been explained by the Centre’s
medical staff and cultural mediators. Adhesion was com-
pletely voluntary and signed informed consent, which
was written in the immigrants mother tongue, was
obtained from 529 volunteers of 744 refugees admitted
to the Centre beetween May-July 2008. Test results
were communicated to refugees and positive cases were
treated in the Infectious Disease Unit of the Local Hos-
pital. Data were stored according to the Italian laws on
privacy.
The Regional Government Authority (Assessorato alle
Politiche della Salute) gave the approval to carry out the
investigation by offering the tests to immigrants and to
use the results of the tests anonymously for scientific
aims. Ethical approval was not required for this study
because the project involved data routinely collected.
The research was carried out in compliance with the
Helsinki Declaration.
The hepatitis B virus surface antigen (HBsAg), the
hepatitis B virus core antibody (anti-HBc) and the hepa-
titis C virus antibody (anti-HCV) were detected by a
third-generation enzyme-linked immunosorbent assay.
This immunoassay method was carried out according to
the instructions of the manufacturer (Abbott prism
Architect AxSYM and Architect Test, Abbott Diagnostic
Division, Italy).
Antibodies to HIV (anti-HIV) were determined by
chemiluminiscent microparticle immunoassay (HIV Ag/
Ab Combo, Abbott Diagnostic Division, Sligo, Ireland)
and positive results were confirmed by line immunoas-
say (INNO-LIA HIV I/II, Immunogenetics GmbH,
Germany).
Venereal Disease Research Laboratory (VDRL) syphilis
screening was also carried out on 269 of the 529 serum
samples (Alfa Wasserman Diagnostic, Milano, Italia).
All patients found positive were treated in the Local
Health Unit following specific care protocols.
D e m o g r a p h i cd a t af r o mt h eA s y l u mC e n t r ed a t a b a s e
and the laboratory exam results were analyzed with the
statistical software Epi-Info 6.00. The Chi-square test
was used for the analysis of the difference between pro-
portions with a value of p < 0.05 considered significant.
Results
A total of 529 refugees (71.1% of the 744 admitted to
the Asylum Centre between May-July 2008), of which
442 males and 87 females, aged between 7 and 52 years
(average = 23.9; SD = 6.7 years), were studied. Table 1
shows study population by sex and by geographic
continent.
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Page 2 of 5Of the total of 529 refugees under study, 44 indivi-
duals (8.3%) were HBsAg positive and 241 (45.6%) anti-
HBc positive. The prevalence of HBsAg positive subjects
was significantly higher in males (9.7%; 95% CI = 7.2-
13.0) than in females (1.1%; 95% CI = 0-6.2; p = 0.008).
The proportion of anti-HBc positive individuals was also
higher in males (48.4%; 95% CI = 43.7-53.2) than in
females (31%; 95% CI = 21.5- 41.9; p = 0.002). There
was no significant average age difference between sero-
positive and sero-negative HBsAg, being respectively
23.8 years (SD = 7.0) and 24 years (SD = 6.7; p >.05),
while for anti-HBc positive and negative individuals
average age was respectively 24.5 years (SD = 7.7) and
23.6 years (SD = 5.7; p > .05). Table 2 shows the distri-
bution of hepatitis B serological markers by geographical
origin.
A total of 24 (4.5%) individuals, 23 males (5.2%; 95%
CI = 3.4-7.9) and 1 female (1.1%; 95% CI = 0-6.3) were
anti-HCV positive. In detail, the figures were 4.3% (95%
CI = 2.8-6.6) for African refugees and 10.5% (95% CI =
1.3- 33.1; p >.05) for Asians (Table 2).
T h ea v e r a g ea g eo fa n t i - H C Vp o s i t i v es u b j e c t s( 2 6 . 5 ,
SD = 7.8) was higher than that of anti-HCV-negative
subjects (23.8, SD = 6.5; p = 0.04).
Three males from Africa were found to be HBsAg/
Anti-HCV positive.
Eight refugees (1.5%), 6 males (1.4%; 95% CI = 0.6-3.1)
and 2 females (2.2%; 95% CI = 0.3-8.5), all from Africa,
were HIV positive. The average age of HIV-positive
individuals was 25.4 (SD = 9.3) without any statistically
significant difference to HIV-negatives (average age =
23.9, SD = 6.6; p >.05).
Two African male refugees were HIV/Anti-HCV
positive.
Four individuals from Africa of the 269 tested (1.5%)
were positive to the VDRL test. Their average age was
26.7 years (SD = 6.2), not significantly different to
VDRL-negatives (average age = 24.9, SD = 7.3; p > .05).
The subjects found with any infection were 65 (12.3%),
with a higher proportion in males (14.3%; 95% CI = 10.9-
17.5) than in females (2.3%; 95% CI = -0.8-5.4;
p = 0.0001). Their average age was 24.5 years (SD = 7.0),
not significantly different to subjects without infection
(23.9; SD = 6.7; p >.05). There was no statistical differ-
ence in continent of origin with an infection rate of
12.4% in Africans (95% CI = 9.7-15.6) and of 10.5% in
Asians (95% CI = 1.3-33.1; p >.05; Table 2).
Discussion
In our study on 529 refugees, almost half of them had
serological markers of past or active infections, that is
8.3% were HBsAg positive, 45.6% were anti-HBc posi-
tive, 4.3% anti-HCV positive and 1.5% HIV-positive.
Various other similar studies have been carried out in
recent years. In a study performed in Verona (Italy) in
2008 among 182 Sub Sahara refugees, HBsAg positives
were 9.3% and HBs/anti-HBc positives were 35.2%, with
anti-HCV positives at 2.7%. In this study only illegal
immigrants attending a volunteer health center have
been analyzed [13].
In a study performed in Greece published in 2008 by
Vasilopoulou et al, HBsAg positives were 27.3% for
Asian refugees, while anti-HBc positives were 45% for
Asian and 25% for African immigrants. The African
refugees also had a rate of anti-HCV positives of 12.5%
[14].
Palumbo et al, in a study carried out in the Italian
province of Foggia in 2007 on 469 refugees, documented
a HBsAg positivity rate of 11.1%, without any difference
between African and Asian subjects. Also this study
used a convenience sample [15].
Our results, in a larger population than the above
three studies, produced similar infection rates though
there are various factors in our study that can give rise
to a selection bias. Many immigrants may not have
volunteered because they refuse contact with authority
figures because of fear of expulsion, others can have
specific cultural or religious beliefs concerning medical
practices. Moreover, some of them could perceive the
hepatitis screening as related with STIs or with sexual
activity in general, or useless for their health. The repu-
tation also could act as a barrier [16].
The study population contained very few Asians.
Table 1 Study population per sex and continent of origin
(No. = 529)
Female Male Total
Continent No. % No. % No.
Africa 87 17 423 83 510
Asia –– 19 100.0 19
Total 87 16.4 442 83.6 529
Table 2 Distribution of hepatitis B and hepatitis C
markers per sex and continent of origin (No. = 529)
Male Female p Africa Asia p
No. 442
(83.6%)
87
(16.4%)
510
(96.4%)
19
(3.6%)
HBsAg(+) 43
(9.7%)
1
(1.1%)
0.008 44
(8.6%)
0 >.05
Anti-HBc (+) 214
(48.4%)
27
(31%)
0.002 234
(45.9%)
7
(36.8%)
>.05
HBsAg (-), anti-HBc
(-)
228
(51.6%)
60
(68.9%)
0.002 276
(54.1%)
12
(63.2%)
>.05
Anti-HCV(+) 23
(5.2%)
1
(1.1%)
>0.5 22
(4.3%)
2
(10.5%)
>.05
Any infection 63
(14.3%)
2
(2.3%)
0.0001 54
(10.5%)
2
(12.4%)
>.05
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Page 3 of 5Finally it was not possible to check vaccination history
because the great majority of primary refugees lacked
documentation for recommended immunizations.
Furthermore, two of the performed tests (anti-HCV
and VDRL) lack specificity for diagnosis true active
infections. In our survey screening tests and not diag-
nostic tests for infections were performed. Screening
tests do not mean the prevalence of infection but the
prevalence of the markers that is important by an epide-
miological perspective.
In the immigrants studied, HBsAg positivity is higher
than in the autochthonous population. A constant ser-
oepidemiological surveillance would seem to be essential
to monitor the prevalence of hepatitis and other infec-
tions so allowing their transmission to be controlled
through counselling and vaccination programs wherever
possible. Already, following the results of this study,
hepatitis-B vaccination is offered free to susceptible
refugees resident in the Asylum Seeker Centre in Bari
Palese.
While the lack of a vaccine makes counselling indis-
pensable for HCV-positive subjects and their cohabi-
tants, this counselling would also be helpful against
other parenterally or sexually transmitted infections.
Even if international guidelines to date recommend only
universal HBV and HIV screening, and HCV screening
according to symptoms, risk factors, etc., recent evi-
dence seems to support the effectiveness of screening
for HCV in populations at risk [17,18]. Our study can
add a contribution to the debate about pros and cons of
HCV screening.
The percentage of HIV positives (1.5%) was higher
than that found in the general Italian population [11].
Immigrants continue therefore to be a risk population
for HIV infection. Although the incidence of new diag-
nosis of HIV infection has decreased in recent years
both in the Italian and the non-Italian population living
in Italy, the difference in incidence between the two
populations has risen, probably because of an increase
in immigration from endemic zones in Africa, where
HIV has been increasing [19,20].
The percentage of those positive for the VDRL test
(1,5%) was much higher than in the general Italian
population, where the prevalence of syphilis is estimated
to be 86 × 100,000 residents [21]. However VDRL may
be positive in non-syphilis treponemal diseases and
indeed in many other conditions and so show a high
rate of false positives [22].
Some limitations affected our observations, such as
the convenience sampling and some of the diagnostic
tests lacking of specificity. Although these limitations,
the results of our investigation appear important to
show this situation in Italy.
Conclusions
Our survey has been carried out during a 3-month per-
iod in a Centre with 2550 immigrants over the course of
a year. Although the conclusions that can be drawn
about the reported subpopulations could be partially
limited, a significant proportion (12.3%) of asympto-
matic refugees presented with at least one condition
potentially associated with long-term complications and
risk of secondary transmission.
In Italy, there is the need for the adoption of a suita-
ble protocol for the early diagnosis of infectious diseases
upon entering the Asylum Centre, to allow the adoption
of prevention measures to safeguard the health of the
individuals, the residents and workers in the Centres.
Testing and improving knowledge of serologic status of
refugees substantially help the managing of infectious
hazard in crowding and at strictly contacts immigration
settings.
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